University of Utah

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Utah sits in the top decile of US sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count).

818 total trials 138 currently recruiting 492 completed early-phase tilt top decile by trial count

University of Utah: 818 sponsored US clinical trials, 138 recruiting.

University of Utah sponsors 818 registered US clinical trials on ClinicalTrials.gov, 138 of them currently recruiting, and 492 completed. 45 of these trials are in Phase 3-4 (later-stage) and 268 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Low Back Pain, with 8 trials.

Top-decile sponsor footprint

University of Utah ranks in the top decile of sponsors by registered trial count (#40 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 41/100

492 of 611 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

818 total, page 7 of 17

COMPLETED NA

Near-infrared Spectroscopy-based Neurofeedback as Adjunct to Mindfulness-Oriented Recovery Enhancement in Persons With Chronic Pain

NCT04902339

TERMINATED Early Phase 1

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

NCT04727632

COMPLETED NA

SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers

NCT04939532

COMPLETED NA

SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers

NCT04939519

COMPLETED NA

A Comprehensive Oncology Rehabilitation and Exercise (CORE) Program Among Breast Cancer Survivors

NCT04594473

TERMINATED Phase 1

Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer

NCT04158349

COMPLETED NA

Image Narrative With College Students

NCT04759313

COMPLETED Phase 2

5-HTP and Creatine for Depression

NCT04395183

COMPLETED NA

The Effect of Combining Spinal Manipulation and Dry Needling in Individuals With Low Back Pain

NCT05802901

COMPLETED NA

Brief Nurse-led Mindfulness Based Intervention

NCT04800354

COMPLETED NA

Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer

NCT04763902

COMPLETED NA

Non-Interruptive Alerts for Improving Use of Clinical Decision Rules

NCT04702308

COMPLETED

Same Day Oral EC and Implant Initiation

NCT04678817

COMPLETED NA

The Effect of 360 Video and MAPS on Enrollment in the DPP

NCT04746781

COMPLETED NA

Functional Precision Oncology for Metastatic Breast Cancer

NCT04450706

COMPLETED Early Phase 1

Asprin Dosing Estimator in Healthy Adults

NCT04040465

COMPLETED

Vascular Health and Risk Factors in Children With Down Syndrome

NCT04735874

TERMINATED Phase 2

Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD

NCT04446182

COMPLETED NA

Pharmacokinetic Evaluation of a Natural CBD Extract

NCT07359976

COMPLETED NA

Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation

NCT04357288

TERMINATED Phase 2

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

NCT04252859

COMPLETED Phase 1

Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients

NCT04497389

COMPLETED NA

Improving Health Insurance Experiences for Adolescent and Young Adult Cancer Patients

NCT04448678

COMPLETED NA

Virtual Coaching to Maximize Dementia Caregivers' Respite Time Use

NCT03689179

COMPLETED Early Phase 1

Pharmacokinetics of Amiloride Nasal Spray in Healthy Volunteers

NCT04181008

TERMINATED NA

Renuvion/J-Plasma for Subdermal Skin Tightening and Contouring of the Upper Arms: Dissection Technique Comparison

NCT04902599

COMPLETED Phase 3

Sun-safe Habits Intervention and Education

NCT04341064

COMPLETED Early Phase 1

Ovarian Function With ENG Implant and UPA Use

NCT04291001

COMPLETED NA

Piloting GETCare: A Remote Goal-based Education and Skills Training Program for Caregivers Poststroke

NCT05403021

COMPLETED NA

Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening

NCT04498052

COMPLETED NA

Telehealth Physical Therapy for Chronic Back Pain - Ancillary Study to NCT03859713

NCT05103462

COMPLETED NA

Exploring Telehealth to Deliver Me & My Wishes During Coronavirus-19

NCT05037448

COMPLETED Phase 3

A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder

NCT04504253

COMPLETED Phase 1

Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)

NCT04281004

COMPLETED NA

Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery

NCT04305756

COMPLETED NA

Telehealth Group Intervention for Perinatal Depressive Symptoms

NCT03932760

TERMINATED NA

Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization

NCT04368000

COMPLETED NA

Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic

NCT04464486

COMPLETED NA

Family Lifestyles, Actions, and Risk Education Intervention: Version 2

NCT04201223

COMPLETED Phase 2

University of Utah COVID-19 Hydrochloroquine Trial

NCT04342169

COMPLETED Early Phase 1

A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure

NCT04319731

COMPLETED Phase 1

Ulixertinib (BVD-523) and Hydroxychloroquine in Patients W Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas

NCT04145297

COMPLETED Early Phase 1

Mechanisms of CBD for Chronic Pain

NCT04044729

COMPLETED NA

Resiliency in Total Joint Arthroplasty

NCT04357262

COMPLETED NA

Broadening the Reach, Impact, and Delivery of Genetic Services

NCT03985852

COMPLETED NA

Patient Doctor Lies

NCT04803448

COMPLETED NA

Pre-Clinical White Matter Changes and Associated Connectivity Effects in Fabry Disease

NCT03678324

COMPLETED

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

NCT04467931

COMPLETED NA

Peer to Peer Programs for Military Suicide Prevention

NCT04021758

COMPLETED Phase 1

Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)

NCT03298815

← Previous Page 7 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 145
Phase 2 123
Phase 3 18
Phase 4 27

What is open in the University of Utah pipeline

138 recruiting of 818 indexed (17% open); 492 completed (60%).

Phase mix: 45 late (III/IV) vs 268 early (I/II) (early-phase heavy).

Top condition: Low Back Pain (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Utah: open-pipeline peers nationwide

Peers matched on 818 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of UtahUniversity of Texas Southwestern Medical CenterUniversity of ChicagoDana-Farber Cancer InstituteUniversity of California, San DiegoUniversity of HawaiiPenn State UniversityAdventHealthCSL Behring
University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Utah sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 818 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this University of Utah page

818 registered trials is a research-attention snapshot, not an endorsement of University of Utah or any single study.

  • 138 of University of Utah's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Low Back Pain is the condition University of Utah studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Low Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Utah pipeline card: 818 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.